✦ LIBER ✦

Follicular low-grade non-Hodgkin's lymphoma: Long-term outcome with or without tumor progression

✍ Scribed by Jens Ersbøll; Henrik B. Schultz; Jens Pedersen-Bjergaard; Nis I. Nissen

Book ID: 114791128
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 571 KB
Volume: 42
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1989.tb01205.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PO39 Long-term survival after histologic

PO39 Long-term survival after histologic transformation from high grade B cell non-Hodgkin's lymphoma to low grade follicular lymphoma and Hodgkin's disease in the same patient

✍ A. Tolosa; A. Escriva; J. Ros; A. Garcia; M. Fernandez; M.J. Sayas; R. Andreu; P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Long-Term Outcome and Prognostic Factors

Long-Term Outcome and Prognostic Factors in Early-Stage Nodal Low-Grade Non-Hodgkin’s Lymphomas Treated with Radiation Therapy

✍ Hans Theodor Eich; Martina Heimann; Hartmut Stützer; Jan Kriz; Marcel Reiser; Ro 📂 Article 📅 2009 🏛 Springer 🌐 German ⚖ 334 KB

Updated Metaanalysis Finds That Interfer

Updated Metaanalysis Finds That Interferon-α Improves Progression-Free and Overall Survival in Low-Grade Non-Hodgkin's Lymphoma When Administered with Chemotherapy That Contains Anthracyclines or Mitoxantrone

✍ Gibson, Angelia D.; Cheson, Bruce D.; Link, Brian; Oken, Martin M. 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 89 KB

Comparison of long-term outcome of child

Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group

✍ Sposto, Richard ;Meadows, Anna T. ;Chilcote, Robert R. ;Steinherz, Peter G. ;Kje 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract ## Background Early Children's Cancer Group (CCG) trials indicated that the cyclophosphamide, vincristine, methotrexate, and prednisone (COMP) regimen was superior to the LSA~2~L~2~regimen for non‐lymphoblastic (NLB) non‐Hodgkin lymphoma (NHL). Studies by other groups suggested that ad